Clinical trial
SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial
NCT03306680 is registered in ClinicalTrials.gov with London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SUNSET: SBRT for Ultra-central NSCLC- a Safety and Efficacy Trial
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- January 19, 2018
- Completion date
- September 30, 2026
- Enrollment
- 30 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer